Human Epidermal Growth Factor Receptor predicts long term outcomes in Ductal Carcinoma In Situ
Australia’s second-largest city extends lockdown
11 August 2021Self-perceived social standing may affect cardiovascular health of Hispanic/Latino adults
11 August 2021Human Epidermal Growth Factor Receptor predicts long term outcomes in Ductal Carcinoma In Situ
New results from researchers at Queen Mary University of London confirm the role of Human Epidermal Growth Factor Receptor (HER2) in predicting long-term outcomes for Ductal Carcinoma In Situ (DCIS), a pre-invasive stage of breast cancer.
